Volume 18, Number 1—January 2012
CME ACTIVITY - Synopsis
Intestinal Toxemia Botulism in 3 Adults, Ontario, Canada, 2006–2008
|Case-patient no.||Age, y/sex||Dates admitted to hospital and discharged||Clinical findings||Gastrointestinal history||Clostridium botulinum serotype||No. days stool sample positive for C. botulinum*||Supportive care; antitoxin; administration date|
|1||63/F||2006 Nov 22||Abdominal pain, diarrhea, dysphagia, diplopia, weakness||Crohn disease, short bowel syndrome, remote bowel surgery||A||61||Intubation and ventilation; bivalent type A and B, monovalent type E; 2006 Nov 23|
|2||50/F||2007 Feb 8; 2007 Sep||Dysphagia, double vision, weakness, difficulty breathing||Crohn disease, bowel resections||A and B||56||Intubation and ventilation; bivalent type A and B, monovalent type E; 2007 Feb 23|
|3||45/M||2008 Jan 8; 2008 Feb 27||Abdominal distension and obstruction, aphonia, diplopia, dry mouth, dysphagia, dysphonia, ptosis||Unremarkable||B||41||Bivalent type A and B, monovalent type E; 2008 Jan 14|
*Total number of days that C. botulinum spores or neurotoxins were detected in clinical samples.
Page created: December 22, 2011
Page updated: December 22, 2011
Page reviewed: December 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.